Peptide Libraray

HAL-2/2

General Information

DRACP ID DRACP00359

Peptide Name HAL-2/2

Sequence GKWMKLLKHILK

Sequence Length 12

UniProt ID Not available

PubChem CID Not available

Origin Synthetic

Type Synthetic peptide

Classification

Active ACP Membrane-targeted

Activity Information

Cell Line	Disease	Cancer Classified	Activity	Assay	Testing Time	Literature
HeLa	Human papillomavirus-related endocervical adenocarcinoma	Carcinoma	IC50=6±1 µM	MTT assay	48 h	1
SW480	Colon adenocarcinoma	Carcinoma	IC50=35±5 µM	MTT assay	48 h	1
CCRF-CEM	Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia	Leukemia	IC50>40 µM	MTT assay	48 h	1

Hemolytic Activity Rat erythrocytes: IC50=87.4 μM

Normal (non-cancerous) Cytotoxicity HUVEC: IC50=40±4 μM

Target Not available

Affinity Not available

Mechanism Not available

Nature Anticancer; Antimicrobial; Antifungal

Structure Information

PDB ID Not available

Predicted Structure DRACP00359

Helicity Not available

Linear/Cyclic Linear

Disulfide/Other Bond Not available

N-terminal Modification Free

C-terminal Modification Amidation

Other Modification None

Chiral L

Physicochemical Information

Formula C72H123N19O13S

Absent amino acids ACDEFNPQRSTVY

Common amino acids K

Mass 169135

Pl 11.28

Basic residues 5

Acidic residues 0

Hydrophobic residues 5

Net charge 5

Boman Index -156

Hydrophobicity -19.17

Aliphatic Index 130

Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour

Extinction Coefficient cystines 5500

Absorbance 280nm 500

Polar residues 1

Amino acid distribution

Literature Information

Literature 1

Pubmed ID 22100226

Title Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells

Doi 10.1016/j.peptides.2011.11.002

Year 2012

Patent

Patent ID Not available

Patent Title Not available

Other Iinformation Not available

Other Published ID Not available